MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 29, 2004; DOI: 10.1124/mol.104.005199


0026-895X/04/6606-1465-1477$20.00
Mol Pharmacol 66:1465-1477, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.005199v1
66/6/1465    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Y. J.
Right arrow Articles by Chen, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Y. J.
Right arrow Articles by Chen, C.-C.

Induction of Cyclooxygenase-2 Overexpression in Human Gastric Epithelial Cells by Helicobacter pylori Involves TLR2/TLR9 and c-Src-Dependent Nuclear Factor-{kappa}B Activation

Ya Jen Chang, Ming Shiang Wu, Jaw Town Lin, Bor Shyang Sheu, Tatsushi Muta, Hiroyasu Inoue, and Ching-Chow Chen

Department of Pharmacology (Y.J.C., C.C.C) and Division of Gastroenterology, Department of Internal Medicine (M.S.W., J.T.L.), College of Medicine, National Taiwan University, and National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan (B.S.S.); Department of Molecular and Cellular Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan (T.M.); and Department of Pharmacology, National Cardiovascular Center Research Institute, Osaka, Japan (H.I.).

Gastric epithelial cells were incubated with a panel of clinical isolates of Helicobacter pylori, including nonulcer dyspepsia with gastritis (HS, n = 20), gastric ulcer (HU, n = 20), duodenal ulcer (HD, n = 21), and gastric cancer (HC, n = 20). HC strains induced a higher cyclooxygenase-2 (COX-2) expression than those from HS, HD, and HU. The bacterial virulence factors and the host cellular pathways were investigated. Virulence genes of iceA, vacA, babA2, cagA 3' repeat region, and hrgA failed to show any association with the disease status and COX-2 expression. Methylation-specific polymerase chain reaction revealed HC strains not affecting the methylation status of COX-2 promoter. Nuclear factor (NF)-{kappa}B, NF-interleukin 6, and cAMP response element were found to be involved in COX-2 induction. We explored a novel NF-{kappa}B activation pathway. The mutants of TLR2 and TLR9, but not TLR4, inhibited H. pylori-induced COX-2 promoter activity, and neutralizing antibodies for TLR2 and TLR9 abolished H. pylori-induced COX-2 expression. Phosphatidylinositol-specific phospholipase C (PI-PLC), protein kinase C (PKC), and Src inhibitors inhibited COX-2 induction. The dominant-negative mutants of NIK and various I{kappa}B kinase complexes, including IKK{beta} (Y188F), IKK{beta} (Y199F), and IKK{beta} (FF), inhibited the COX-2 promoter activity. Phosphorylation of GST-IKK{beta} (132-206) at Tyr188 and Tyr199 by c-Src was found after H. pylori infection. In summary, H. pylori induces COX-2 expression via activations of NF-{kappa}B, NF-interleukin 6, the cAMP response element. In NF-{kappa}B activation, H. pylori acts through TLR2/TLR9 to activate both the cascade of PI-PLC{gamma}/PKC{alpha}/c-Src/IKK{alpha}/{beta} and the cascade of NIK/IKK{alpha}/{beta}, resulting in the I{kappa}B{alpha} degradation and the expression of COX-2 gene. The COX-2 overexpression may contribute to the carcinogenesis in patients colonized with these strains.


Received July 21, 2004; accepted September 20, 2004

Address correspondence to: Dr. Ching-Chow Chen, Department of Pharmacology, College of Medicine, National Taiwan University, No.1, Jen-Ai Road, 1st Section, Taipei 10018, Taiwan. E-mail: ccchen{at}ha.mc.ntu.edu.tw




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
Y.-H. Wang, J.-J. Wu, and H.-Y. Lei
The Autophagic Induction in Helicobacter pylori-Infected Macrophage
Experimental Biology and Medicine, February 1, 2009; 234(2): 171 - 180.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I-T. Lee, S.-W. Wang, C.-W. Lee, C.-C. Chang, C.-C. Lin, S.-F. Luo, and C.-M. Yang
Lipoteichoic Acid Induces HO-1 Expression via the TLR2/MyD88/c-Src/NADPH Oxidase Pathway and Nrf2 in Human Tracheal Smooth Muscle Cells
J. Immunol., October 1, 2008; 181(7): 5098 - 5110.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Slevogt, L. Maqami, K. Vardarowa, W. Beermann, A. C. Hocke, J. Eitel, B. Schmeck, A. Weimann, B. Opitz, S. Hippenstiel, et al.
Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms
Eur. Respir. J., April 1, 2008; 31(4): 725 - 735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Ueno, T. Koga, K. Kato, D. T. Golenbock, S. J. Gendler, H. Kai, and K. C. Kim
MUC1 Mucin Is a Negative Regulator of Toll-Like Receptor Signaling
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 263 - 268.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Hisatsune, E. Yamasaki, M. Nakayama, D. Shirasaka, H. Kurazono, Y. Katagata, H. Inoue, J. Han, J. Sap, K. Yahiro, et al.
Helicobacter pylori VacA Enhances Prostaglandin E2 Production through Induction of Cyclooxygenase 2 Expression via a p38 Mitogen-Activated Protein Kinase/Activating Transcription Factor 2 Cascade in AZ-521 Cells
Infect. Immun., September 1, 2007; 75(9): 4472 - 4481.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Obonyo, M. Sabet, S. P. Cole, J. Ebmeyer, S. Uematsu, S. Akira, and D. G. Guiney
Deficiencies of Myeloid Differentiation Factor 88, Toll-Like Receptor 2 (TLR2), or TLR4 Produce Specific Defects in Macrophage Cytokine Secretion Induced by Helicobacter pylori
Infect. Immun., May 1, 2007; 75(5): 2408 - 2414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. T. Chiu, W. Y. Leung, M. P. Moyer, R. M. Strieter, and E. Rozengurt
Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-{kappa}B
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C767 - C777.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. D. N'Guessan, M. O. Etouem, B. Schmeck, A. C. Hocke, S. Scharf, K. Vardarova, B. Opitz, A. Flieger, N. Suttorp, and S. Hippenstiel
Legionella pneumophila-induced PKC{alpha}-, MAPK-, and NF-{kappa}B-dependent COX-2 expression in human lung epithelium
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L267 - L277.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. K. Damas, M. Jensenius, T. Ueland, K. Otterdal, A. Yndestad, S. S. Froland, J.-M. Rolain, B. Myrvang, D. Raoult, and P. Aukrust
Increased Levels of Soluble CD40L in African Tick Bite Fever: Possible Involvement of TLRs in the Pathogenic Interaction between Rickettsia africae, Endothelial Cells, and Platelets
J. Immunol., August 15, 2006; 177(4): 2699 - 2706.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Chun and A. Prince
Activation of Ca2+-Dependent Signaling by TLR2
J. Immunol., July 15, 2006; 177(2): 1330 - 1337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-J. Chang, M.-S. Wu, J.-T. Lin, and C.-C. Chen
Helicobacter pylori-Induced Invasion and Angiogenesis of Gastric Cells Is Mediated by Cyclooxygenase-2 Induction through TLR2/TLR9 and Promoter Regulation
J. Immunol., December 15, 2005; 175(12): 8242 - 8252.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics